Compliance to regulatory requirements and quality assurance of drug products are the foundation of the global healthcare sector. All medications taken by patients have to be of assured safety, efficacy and consistency, which relies on strict compliance with established regulatory and quality system requirements.
Regulatory authorities, including U.S. FDA, EMA, WHO and CDSCO have created multiple staged frameworks that describe how to manufacture drugs while ensuring that manufactured products are compliant to predetermined quality standards.
This article discusses the meaning of compliance in the pharmaceutical industry, how it affects the quality of drug products and why both compliance and quality assurance are essential for the protection of patients and the success of an organization.
Pharmaceutical compliance involves the operation of a business in compliance with ethical and scientific guidelines set out by governing bodies. If a business fails to follow these guidelines there will be consequences for the company such as regulatory action against them, loss of products from their shelves (recalls), warnings from regulatory bodies or even loss of the right to manufacture.
Pharmaceutical companies comply with the following guidelines:
GMP (Good Manufacturing Practices)
GLP (Good Laboratory Practices)
GCP (Good Clinical Practices)
GDP (Good Distribution Practices)
Pharmacovigilance (the process by which drug companies determine patient reaction to drugs after they enter the market)
In combination, these ensure that any pharmaceutical that reaches a patient is of a certain quality, safe to use and effective in treatment.
Compliance is the minimum requirement and must be met legally. While quality is a philosophy of continual improvement that exceeds compliance.
In other words:
Compliance = Following the law & meeting regulations.
Quality = Doing the correct thing for the product and the patient.
A compliant system leads to quality products and a good quality culture leads to compliance.
The core elements of the ZMS are as follows:
1. Quality Policy: The company's pledge to provide high-quality products and comply with all requirements.
2. Organizational Structure: Organizational roles are there to define the function of quality regions.
3. Change Controls: A process to identify and validate the potential impact of a prior to affecting the quality of the products.
4. Deviant Management: Documentation of an event that occurs outside of the established process, along with all documentation that led to the deviant occurring.
5. Corrective and preventative actions: Opportunities identified for continuous quality improvement.
6. Risk Management: Risk is identified, evaluated, and controlled per ICH Q9 Quality Risk Management principles.
7. Senior Management Review: Senior leaders conduct an on-going review of the effectiveness of the ZMS.
A strong Quality Management System will ensure that each phase of the manufacturing process will produce quality products; from obtaining raw materials to the shipment of the final products.
1. Electronic Quality Management Systems (eQMS) - Automate deviations, CAPA and audit management.
2. Data Integrity Software - Provides real-time access to audit trails and safety of data.
3. IoT Based Monitoring Systems - Monitor continuously temperature, humidity, equipment use and performance.
4. AI and Predictive Analytics - Predict compliance issues prior to them leading to a deviation.
Technology increases efficiency but also enhances transparency and traceability of products built upon the foundation of trust between regulators and manufacturers of pharmaceuticals.
This article discusses the meaning of compliance in the pharmaceutical industry, how it affects the quality of drug products and why both compliance and quality assurance are essential for the protection of patients and the success of an organization.
What Is Pharmaceutical Compliance?
The words "pharmaceutical compliance" mean abiding by all relevant legislation or regulations, guidelines relating to drug development, as well as the rules within any given organization about how they manufacture, test and distribute drugs. The pharmaceutical lifecycle covers everything from R&D through to monitoring after the product is on the market.Pharmaceutical compliance involves the operation of a business in compliance with ethical and scientific guidelines set out by governing bodies. If a business fails to follow these guidelines there will be consequences for the company such as regulatory action against them, loss of products from their shelves (recalls), warnings from regulatory bodies or even loss of the right to manufacture.
Pharmaceutical companies comply with the following guidelines:
GMP (Good Manufacturing Practices)
GLP (Good Laboratory Practices)
GCP (Good Clinical Practices)
GDP (Good Distribution Practices)
Pharmacovigilance (the process by which drug companies determine patient reaction to drugs after they enter the market)
In combination, these ensure that any pharmaceutical that reaches a patient is of a certain quality, safe to use and effective in treatment.
The Relationship Between Compliance and Quality
Quality and compliance are closely related. Compliance refers to meeting regulations, while quality refers to regularly satisfying both product specifications and patient requirements.Compliance is the minimum requirement and must be met legally. While quality is a philosophy of continual improvement that exceeds compliance.
In other words:
Compliance = Following the law & meeting regulations.
Quality = Doing the correct thing for the product and the patient.
A compliant system leads to quality products and a good quality culture leads to compliance.
Importance of Compliance in the Pharmaceutical Industry
1. Patient Safety
Drugs impact human beings directly and any non-compliant products can put patients at risk or give the wrong amount of effectiveness.2. Regulatory Approval and Market Access
In order to approve product licenses or export permits, regulators will require a company to provide documented evidence of process compliance with GMPs.3. Business Reputation and Trust
Building trust among health care providers, patients, and regulators requires compliance while failing to comply negatively affects the reputation of an organization on an ongoing basis.4. Cost and Risk Management
By being proactive with compliance, the organization will reduce the risks associated with excessive recalls, failure to meet quality requirements, and potential penalties resulting from failure to comply thus creating reduced long-term costs.Key Regulatory Frameworks for Pharmaceutical Compliance
1. Good Manufacturing Practice (GMP)
GMP provides assurance that what is manufactured will meet consistent standards in quality, is produced in compliance with regulations, and how an entity is manufactured.2. Good Laboratory Practice (GLP)
Definitions of GLP develop the guidelines for conducting non-clinical lab studies, and establishing reliable and verifiable data on analytical and toxicology.3. Good Clinical Practice (GCP)
GCP provides the principle behind designing and conducting clinical trials to ensure ethical, and scientific integrity when conducting clinical trials, and assures the rights and safety of clinical trial volunteers.4. Good Distribution Practices (GDP)
The guidelines for preserving and maintaining the quality of medication products throughout all elements of the supply chain (i.e. - Center Storage to End User). Providing assurance that there will not be a reduction in quality of products due to poor storage or shipping procedures.5. Data Integrity Regulations
Data integrity is based on the principles of ALCOA+ and provide the basis of having pure and verifiable records for every function performed.Pharmaceutical Quality Management System (QMS)
The purpose of the Quality Management System (ZMS) is to combine all processes and practices that have an impact on product quality and compliance. The ICH Q10 Pharmaceutical Quality system acts as an international model for developing the ZMS in the pharmaceutical industry.The core elements of the ZMS are as follows:
1. Quality Policy: The company's pledge to provide high-quality products and comply with all requirements.
2. Organizational Structure: Organizational roles are there to define the function of quality regions.
3. Change Controls: A process to identify and validate the potential impact of a prior to affecting the quality of the products.
4. Deviant Management: Documentation of an event that occurs outside of the established process, along with all documentation that led to the deviant occurring.
5. Corrective and preventative actions: Opportunities identified for continuous quality improvement.
6. Risk Management: Risk is identified, evaluated, and controlled per ICH Q9 Quality Risk Management principles.
7. Senior Management Review: Senior leaders conduct an on-going review of the effectiveness of the ZMS.
A strong Quality Management System will ensure that each phase of the manufacturing process will produce quality products; from obtaining raw materials to the shipment of the final products.
Factors Impacting Product Quality
The quality of pharmaceutical products is based on three primary elements: the product's process, the people involved in its manufacture and the systems used to make it.1. Raw Materials
All incoming raw materials need to be purchased from qualified suppliers with the proper testing completed prior to use that includes the determination of identity, purity and potency. Raw material variability can directly impact the quality of the final product produced.2. Process Validation
All methods used during the manufacturing of a product must be validated prior to production. Validation of all manufacturing processes is required to demonstrate that each process will produce the desired result consistently. This will include validation of mixing, granulation, compression, filling and sterilization.3. Equipment Qualification
Installation qualification (IQ), operational qualification (OQ) and performance qualification (PQ) provides the documentation that the equipment operates as specified and expected.4. Environmental Controls
Environmental controls for the cleanroom, including classification of the cleanroom's cleanliness, appropriate air filtration and control of temperature and humidity, play an important role in the prevention of contamination.5. Personnel Training
Personnel working in a pharmaceutical plant must be competent and trained for the position they are occupying. Employee training must include good manufacturing practices (GMPs), good safety practices and company-expected documentation practices.6. Documentation
Completeness and accuracy of documentation provide traceability and accountability, both of which are important expectations of regulatory agencies.7. Audits and Self-Inspections
Routine internal audits conducted during an annual schedule will ensure that any compliance deficiency is identified and led to close out to drive continuous improvement.Common Compliance Challenges
Even with their best efforts, pharmaceutical companies deal with many types of compliance issues including:- Issues with data integrity due to poor documentation or not managing electronic record adequately.
- Failure to manage deviations has led to repeated compliance issues.
- SOP are outdated and don’t reflect how things are currently done.
- Incomplete training records or staff not being qualified.
- Risks to the supply chain because there isn’t sufficient oversight of vendors.
- System change due to new regulations.
Role of Technology in Enhancing Compliance and Quality
Digital transformation can influence how pharmaceuticals manage compliance.1. Electronic Quality Management Systems (eQMS) - Automate deviations, CAPA and audit management.
2. Data Integrity Software - Provides real-time access to audit trails and safety of data.
3. IoT Based Monitoring Systems - Monitor continuously temperature, humidity, equipment use and performance.
4. AI and Predictive Analytics - Predict compliance issues prior to them leading to a deviation.
Technology increases efficiency but also enhances transparency and traceability of products built upon the foundation of trust between regulators and manufacturers of pharmaceuticals.
Building a Culture of Compliance
Building a culture of compliance is not just about building a compliance program; it is about building compliance into the fabric of the organization. Employees will be more likely to make decisions in alignment with compliance and quality when they have a culture of quality.Some Key Strategies for Building a Culture of Compliance:
1. Management commitment to compliance and quality.
2. Regular training and awareness of compliance and quality.
3. Open communication and feedback mechanisms.
4. Rewarding employees for compliance-related behavior.
A strong culture of compliance will result in a sustainable business and have credibility with regulatory agencies for several years.
1. Recall of products, loss of customer confidence.
2. Regulatory Warning Letters or Import Alerts.
3. Corporate penalties and operational interruptions.
4. Legal liability of the Corporation, damage to the Corporation's reputation.
Failure to comply with regulations results in financial loss to the Corporation and presents a serious risk to the health and safety of patients — the ultimate responsibility of every pharmaceutical manufacturer.
Patient safety and business integrity both rely heavily on the interdependent nature of pharmaceutical compliance and product quality together. Regulations may provide a framework, but achieving true compliance depends upon developing an organization-wide commitment to establishing a culture of quality.
When a company places a premium on compliance, it creates an environment of trust among various stakeholders such as regulators, clinicians and ultimately, patients. Through the embracing of continuous improvement, digital innovation and creating a culture of quality within their respective organizations, pharmaceutical companies are able to provide safe, effective and dependable medicines globally.
Therefore, for a pharmaceutical company compliance is more than just a requirement to meet rather it is their belief or commitment to excellence and to sustaining life itself.
1. Management commitment to compliance and quality.
2. Regular training and awareness of compliance and quality.
3. Open communication and feedback mechanisms.
4. Rewarding employees for compliance-related behavior.
A strong culture of compliance will result in a sustainable business and have credibility with regulatory agencies for several years.
Consequences of Non-Compliance
The consequences of failing to adhere to pharmaceutical regulations can be extreme:1. Recall of products, loss of customer confidence.
2. Regulatory Warning Letters or Import Alerts.
3. Corporate penalties and operational interruptions.
4. Legal liability of the Corporation, damage to the Corporation's reputation.
Failure to comply with regulations results in financial loss to the Corporation and presents a serious risk to the health and safety of patients — the ultimate responsibility of every pharmaceutical manufacturer.
Patient safety and business integrity both rely heavily on the interdependent nature of pharmaceutical compliance and product quality together. Regulations may provide a framework, but achieving true compliance depends upon developing an organization-wide commitment to establishing a culture of quality.
When a company places a premium on compliance, it creates an environment of trust among various stakeholders such as regulators, clinicians and ultimately, patients. Through the embracing of continuous improvement, digital innovation and creating a culture of quality within their respective organizations, pharmaceutical companies are able to provide safe, effective and dependable medicines globally.
Therefore, for a pharmaceutical company compliance is more than just a requirement to meet rather it is their belief or commitment to excellence and to sustaining life itself.
No comments:
Post a Comment
Please don't spam. Comments having links would not be published.